109 results
Page 3 of 6
8-K
EX-99.1
8j6tys6ivpkq p0o
10 May 22
Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business Highlights
7:37am
8-K
EX-1.1
0a6ago4
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
424B5
xgylsijx 01987
14 Apr 22
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
wdaqykdb vw9ds
12 Apr 22
Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency and ENPP1 Deficiency
7:37am
8-K
eid6y0nptwbzk9yqp
12 Apr 22
Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency and ENPP1 Deficiency
7:37am
8-K
57sqsy
4 Apr 22
Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency
7:39am
8-K
EX-99.1
ctx5y2ktfwzp46t
4 Apr 22
Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency
7:39am
8-K
EX-99.1
m04k6cocbumkiprgv
15 Mar 22
Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights
5:30pm
8-K
EX-99.1
m2p i4t2iwr7zxidgs
8 Mar 22
Inozyme Pharma Strengthens Management Team with Two Executive Appointments
7:41am
S-3
EX-4.4
qgrvky 58wfeb2ais79q
11 Aug 21
Shelf registration
7:12am
S-3
EX-1.2
wwv5k tlmkgy0s
11 Aug 21
Shelf registration
7:12am
S-3
ndgk9gedm8as0w3kh
11 Aug 21
Shelf registration
7:12am
S-3
EX-4.3
u4qywv
11 Aug 21
Shelf registration
7:12am